Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial
Author:
Affiliation:
1. Department of Cardiology; Bern University Hospital; Bern Switzerland
2. Department of Advanced Biomedical Sciences; Federico II University of Naples; Italy
3. Thoraxcenter, Erasmus Medical Center; Rotterdam The Netherlands
Funder
European Association of Percutaneous Cardiovascular Intervention
Veronesi Foundation-Cardiovascular research
Italian Society of Cardiology
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26921/fullpdf
Reference30 articles.
1. 2014 acc/aha/aats/pcna/scai/sts focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the american college of cardiology/american heart association task force on practice guidelines, and the american association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons;Fihn;Circulation,2014
2. 2014 esc/eacts guidelines on myocardial revascularization;Windecker;EuroIntervention,2015
3. Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials;Navarese;BMJ,2015
4. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: A pairwise and bayesian network meta-analysis of randomised trials;Palmerini;Lancet,2015
5. Meta-analyses of dual antiplatelet therapy following drug-eluting stent implantation: Do bleeding and stent thrombosis weigh similar on mortality?;Capodanno;J Am Coll Cardiol,2015
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Double Trouble: Dual Antiplatelet Therapy Duration Dilemma in Chronic Kidney Disease Patients With High Bleeding Risk;The American Journal of Cardiology;2024-09
2. One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease;The American Journal of Cardiology;2024-08
3. Acute myocardial infarction and chronic kidney disease: A nationwide cohort study on management and outcomes from 2010-2022;Clinical Journal of the American Society of Nephrology;2024-07-18
4. Early Discontinuation of Aspirin Among Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention with a Drug-Eluting Stent: A Meta-Analysis;Kidney360;2023-08-01
5. Clinical Outcomes of Prolonged Antiplatelet Therapy after Percutaneous Coronary Intervention in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis;Blood Purification;2022-12-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3